{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:07:28Z","timestamp":1786982848004,"version":"build-2736575974"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2023,3,16]],"date-time":"2023-03-16T00:00:00Z","timestamp":1678924800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,3,16]],"date-time":"2023-03-16T00:00:00Z","timestamp":1678924800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"DOI":"10.1007\/s40618-023-02064-w","type":"journal-article","created":{"date-parts":[[2023,3,26]],"date-time":"2023-03-26T20:03:11Z","timestamp":1679860991000},"page":"1935-1940","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["The importance of hypophosphatemia in the clinical management of primary hyperparathyroidism"],"prefix":"10.1007","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5478-3192","authenticated-orcid":false,"given":"H.","family":"D\u00fc\u011fer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Bostan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00dc.","family":"G\u00fcl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"U\u00e7an","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Hep\u015fen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Sak\u0131z","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Akhanl\u0131","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"\u00c7akal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"K\u0131z\u0131lg\u00fcl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,3,16]]},"reference":[{"key":"2064_CR1","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1038\/nrendo.2017.104","volume":"14","author":"MD Walker","year":"2018","unstructured":"Walker MD, Silverberg SJ (2018) Primary hyperparathyroidism. Nat Rev Endocrinol 14:115\u2013125. https:\/\/doi.org\/10.1038\/nrendo.2017.104","journal-title":"Nat Rev Endocrinol"},{"key":"2064_CR2","doi-asserted-by":"publisher","first-page":"3561","DOI":"10.1210\/jc.2014-1413","volume":"99","author":"JP Bilezikian","year":"2014","unstructured":"Bilezikian JP, Brandi ML, Eastell R, Silverberg SJ, Udelsman R, Marcocci C, Potts JT Jr (2014) Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the fourth international workshop. J Clin Endocrinol Metab 99:3561\u20133569. https:\/\/doi.org\/10.1210\/jc.2014-1413","journal-title":"J Clin Endocrinol Metab"},{"key":"2064_CR3","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.surg.2018.04.088","volume":"165","author":"Y Assadipour","year":"2019","unstructured":"Assadipour Y, Zhou H, Kuo EJ, Haigh PI, Adams AL, Yeh MW (2019) End-organ effects of primary hyperparathyroidism: a population-based study. Surgery 165:99\u2013104. https:\/\/doi.org\/10.1016\/j.surg.2018.04.088","journal-title":"Surgery"},{"key":"2064_CR4","doi-asserted-by":"publisher","first-page":"3172","DOI":"10.1136\/bmj.g3172","volume":"348","author":"P Glendenning","year":"2014","unstructured":"Glendenning P, Bell DA, Clifton-Bligh RJ (2014) Investigating hypophosphataemia. BMJ 348:3172. https:\/\/doi.org\/10.1136\/bmj.g3172","journal-title":"BMJ"},{"key":"2064_CR5","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s00240-007-0096-2","volume":"35","author":"CV Odvina","year":"2007","unstructured":"Odvina CV, Sakhaee K, Heller HJ, Peterson RD, Poindexter JR, Padalino PK, Pak CY (2007) Biochemical characterization of primary hyperparathyroidism with and without kidney stones. Urol Res 35:123\u2013128. https:\/\/doi.org\/10.1007\/s00240-007-0096-2","journal-title":"Urol Res"},{"key":"2064_CR6","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1016\/S0039-6060(96)80051-1","volume":"120","author":"JA S\u00f6reide","year":"1996","unstructured":"S\u00f6reide JA, van Heerden JA, Grant CS, Lo CY, Ilstrup DM (1996) Characteristics of patients surgically treated for primary hyperparathyroidism with and without renal stones. Surgery 120:1033\u20131038. https:\/\/doi.org\/10.1016\/S0039-6060(96)80051-1","journal-title":"Surgery"},{"key":"2064_CR7","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1210\/clinem\/dgab676","volume":"107","author":"E Castellano","year":"2022","unstructured":"Castellano E, Attanasio R, Boriano A, Pellegrino M, Borretta G (2022) Serum phosphate: a neglected test in the clinical management of primary hyperparathyroidism. J Clin Endocrinol Metab 107:612\u2013618. https:\/\/doi.org\/10.1210\/clinem\/dgab676","journal-title":"J Clin Endocrinol Metab"},{"key":"2064_CR8","doi-asserted-by":"publisher","first-page":"94","DOI":"10.5222\/MMJ.2018.59837","volume":"33","author":"M K\u0131z\u0131lg\u00fcl","year":"2018","unstructured":"K\u0131z\u0131lg\u00fcl M, Cal\u0131\u015fkan M, U\u00e7an B, Beysel S, Tak\u0131r M, Sencar E, Sak\u0131z D, \u00c7akal E, \u00d6zbek M (2018) Monocyte to HDL cholesterol ratio and its association with cardio-metabolic risk factors in primary hyperparathyroidism. Medeni Med J 33:94\u201399. https:\/\/doi.org\/10.5222\/MMJ.2018.59837","journal-title":"Medeni Med J"},{"key":"2064_CR9","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1007\/s00198-014-2655-z","volume":"25","author":"ES Siris","year":"2014","unstructured":"Siris ES, Adler R, Bilezikian J, Bolognese M, Dawson-Hughes B, Favus MJ, Harris ST, Jan de Beur SM, Khosla S, Lane NE, Lindsay R, Nana AD, Orwoll ES, Saag K, Silverman S, Watts NB (2014) The clinical diagnosis of osteoporosis: a position statement from the national bone health alliance working group. Osteoporos Int 25:1439. https:\/\/doi.org\/10.1007\/s00198-014-2655-z","journal-title":"Osteoporos Int"},{"key":"2064_CR10","doi-asserted-by":"publisher","first-page":"R147","DOI":"10.1186\/cc9215","volume":"14","author":"DA Geerse","year":"2010","unstructured":"Geerse DA, Bindels AJ, Kuiper MA, Roos AN, Spronk PE, Schultz MJ (2010) Treatment of hypophosphatemia in the intensive care unit: a review. Crit Care 14:R147. https:\/\/doi.org\/10.1186\/cc9215","journal-title":"Crit Care"},{"key":"2064_CR11","doi-asserted-by":"publisher","first-page":"295","DOI":"10.3906\/sag-1806-181","volume":"49","author":"M \u00c7al\u0131\u015fkan","year":"2019","unstructured":"\u00c7al\u0131\u015fkan M, K\u0131z\u0131lg\u00fcl M, Beysel S, U\u00e7an B, Akcan F, Tak\u0131r M, \u00d6zbek M, \u00c7akal E (2019) Factors associated with glomerular filtration rate variation in primary hyperparathyroidism after parathyroidectomy. Turk J Med Sci 49:295\u2013300. https:\/\/doi.org\/10.3906\/sag-1806-181","journal-title":"Turk J Med Sci"},{"key":"2064_CR12","first-page":"1196","volume-title":"Williams textbook of endocrinology","author":"FR Bringhurst","year":"2020","unstructured":"Bringhurst FR, Demay MB, Kronenberg HM (2020) Hormones and Disorders of Mineral Metabolism. In: Melmed S, Auchus RJ, Goldfine AB, Koenig RJ, Rosen CJ (eds) Williams textbook of endocrinology, 14th edn. Elsevier, Philadelphia, pp 1196\u20131255","edition":"14"},{"key":"2064_CR13","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1530\/EDM-20-0217","volume":"2021","author":"J Alexander","year":"2021","unstructured":"Alexander J, Nagi D (2021) Isolated Hypophosphataemia as an Early Marker of Primary Hyperparathyroidism. Endocrinol Diab Metab Case Reports 2021:20\u20130217. https:\/\/doi.org\/10.1530\/EDM-20-0217","journal-title":"Endocrinol Diab Metab Case Reports"},{"key":"2064_CR14","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1038\/ncpneph0124","volume":"2","author":"J Amanzadeh","year":"2006","unstructured":"Amanzadeh J, Reilly RF Jr (2006) Hypophosphatemia: an evidence-based approach to its clinical consequences and management. Nat Clin Pract Nephrol 2:136\u2013148. https:\/\/doi.org\/10.1038\/ncpneph0124","journal-title":"Nat Clin Pract Nephrol"},{"key":"2064_CR15","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/S0140-6736(09)60507-9","volume":"374","author":"WD Fraser","year":"2009","unstructured":"Fraser WD (2009) Hyperparathyroidism. Lancet 374:145\u2013158. https:\/\/doi.org\/10.1016\/S0140-6736(09)60507-9","journal-title":"Lancet"},{"key":"2064_CR16","doi-asserted-by":"publisher","first-page":"1756","DOI":"10.1210\/clinem\/dgab768","volume":"107","author":"BL Clarke","year":"2022","unstructured":"Clarke BL (2022) Is Moderate hypophosphatemia a new indication for surgery in asymptomatic primary hyperparathyroidism? J Clin Endocrinol Metab 107:1756\u20131757. https:\/\/doi.org\/10.1210\/clinem\/dgab768","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2064_CR17","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1007\/s12020-020-02276-7","volume":"68","author":"B Madeo","year":"2020","unstructured":"Madeo B, De Vincentis S, Repaci A, Altieri P, Vicennati V, Kara E, Vescini F, Amadori P, Balestrieri A, Pagotto U, Simoni M, Rochira V (2020) The calcium-to-phosphorous (Ca\/P) ratio in the diagnosis of primary hyperparathyroidism and hypoparathyroidism: a multicentric study. Endocrine 68(3):679\u2013687. https:\/\/doi.org\/10.1007\/s12020-020-02276-7","journal-title":"Endocrine"},{"issue":"11","key":"2064_CR18","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1530\/EC-21-0267","volume":"10","author":"M Yin","year":"2021","unstructured":"Yin M, Liu Q, Wang Q, He Y, Song H, Nie X, Li G (2021) Diagnostic performance of the calcium\/phosphate ratio for primary hyperparathyroidism in southwest China. Endocr Connect. 10(11):1387\u20131392. https:\/\/doi.org\/10.1530\/EC-21-0267","journal-title":"Endocr Connect."},{"key":"2064_CR19","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1111\/cen.12062","volume":"78","author":"CN Jayasena","year":"2013","unstructured":"Jayasena CN, Modi M, Palazzo F, De Silva A, Donaldson M, Meeran K, Dhillo WS (2013) Associations of serum 25-hydroxyvitamin D with Circulating PTH, phosphate and calcium in patients with primary hyperparathyroidism. Clin Endocrinol (Oxf) 78:838\u2013843. https:\/\/doi.org\/10.1111\/cen.12062","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2064_CR20","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1053\/j.ajkd.2011.06.011","volume":"58","author":"JH Ix","year":"2011","unstructured":"Ix JH, Chonchol M, Laughlin GA, Shlipak MG, Whooley MA (2011) Relation of sex and estrogen therapy to serum fibroblast growth factor 23, serum phosphorus, and urine phosphorus: the heart and soul study. Am J Kidney Dis 58:737\u2013745. https:\/\/doi.org\/10.1053\/j.ajkd.2011.06.011","journal-title":"Am J Kidney Dis"}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-023-02064-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40618-023-02064-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-023-02064-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,27]],"date-time":"2023-07-27T01:22:28Z","timestamp":1690420948000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40618-023-02064-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,16]]},"references-count":20,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2023,9]]}},"alternative-id":["2064"],"URL":"https:\/\/doi.org\/10.1007\/s40618-023-02064-w","relation":{},"ISSN":["1720-8386"],"issn-type":[{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,16]]},"assertion":[{"value":"13 September 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 March 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no conflict of interests to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research involving human participants and\/or animals"}},{"value":"For this type of study, formal consent is not required.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}